Ephraim Philip Lansky Selected Research

Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)

1/2003

Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ephraim Philip Lansky Research Topics

Disease

2	Epilepsy (Aura) 11/2006 - 01/2006
1	Crohn Disease (Crohn's Disease) 10/2013
1	Drug Resistant Epilepsy 01/2006
1	Temporal Lobe Epilepsy 01/2006
1	Prostatic Neoplasms (Prostate Cancer) 03/2005
1	Breast Neoplasms (Breast Cancer) 01/2003

Drug/Important Bio-Agent (IBA)

1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013
1	Immunologic Factors (Immunomodulators)IBA 10/2013
1	SteroidsIBA 10/2013
1	Dronabinol (THC)FDA LinkGeneric 10/2013
1	Artificial Membranes (Artificial Membrane)IBA 03/2005
1	punicic acidIBA 03/2005
1	LuteolinIBA 03/2005
1	caffeic acidIBA 03/2005
1	matrigelIBA 03/2005
1	Ellagic AcidIBA 03/2005
1	PolyphenolsIBA 01/2003
1	Estrogens (Estrogen)FDA Link 01/2003
1	ProstaglandinsIBA 01/2003
1	Interleukin-4 (Interleukin 4)IBA 01/2003
1	Conditioned Culture MediaIBA 01/2003
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2003

Therapy/Procedure

2	Meditation 11/2006 - 01/2006
1	Remission Induction 10/2013
1	Therapeutics 10/2013